Oppenheimer & Co. Inc. Acquires 7,009 Shares of Vanguard Mega Cap Growth ETF $MGK

Oppenheimer & Co. Inc. acquired a new stake in Vanguard Mega Cap Growth ETF (NYSEARCA:MGK) during the third quarter, according to its most recent filing with the SEC. The firm acquired 7,009 shares of the company’s stock, valued at approximately $649,000.

A number of other hedge funds have also recently bought and sold shares of MGK. Park Avenue Securities LLC acquired a new position in shares of Vanguard Mega Cap Growth ETF during the third quarter valued at $13,865,000. Vantagepoint Investment Advisers LLC acquired a new stake in Vanguard Mega Cap Growth ETF in the third quarter worth about $397,940,000. Flagship Harbor Advisors LLC raised its holdings in Vanguard Mega Cap Growth ETF by 5.4% during the 3rd quarter. Flagship Harbor Advisors LLC now owns 11,247 shares of the company’s stock worth $1,042,000 after purchasing an additional 577 shares during the last quarter. CPR Investments Inc. bought a new stake in Vanguard Mega Cap Growth ETF during the 3rd quarter worth about $309,000. Finally, Apollon Wealth Management LLC raised its holdings in Vanguard Mega Cap Growth ETF by 146.7% during the 3rd quarter. Apollon Wealth Management LLC now owns 33,695 shares of the company’s stock worth $3,122,000 after purchasing an additional 20,035 shares during the last quarter.

Vanguard Mega Cap Growth ETF Trading Up 1.5%

Vanguard Mega Cap Growth ETF stock opened at $87.77 on Thursday. Vanguard Mega Cap Growth ETF has a 1 year low of $70.32 and a 1 year high of $95.53. The company has a market cap of $33.28 billion, a PE ratio of 28.83 and a beta of 1.25. The company’s 50-day moving average is $91.00 and its two-hundred day moving average is $85.38.

Vanguard Mega Cap Growth ETF Company Profile

The Vanguard Mega Cap Growth ETF (MGK) is an exchange-traded fund that is based on the CRSP US Mega Growth index. The fund tracks the CRSP US Mega Cap Growth Index. The index selects stocks from the top 70% of investable market capitalization based on growth factors. MGK was launched on Dec 17, 2007 and is managed by Vanguard.